KOHEN AVOCATS FIRM · PARIS 16
FDA Recalls 4.3 Million Toothpaste Tubes: What French Law Gives You If You Bought a Defective Product

Hassan KOHEN acts in urgent matters, from the police station to the assize court. Initial strategic analysis: €80 incl. VAT, personal reply within 24 hours.

100% confidential · Legal professional privilege · No obligation

Article generated by artificial intelligence, through a process designed and supervised by the firm

Source: French Court of Cassation – Judilibre and Légifrance open data

Paris Bar Police custody, investigation, assize court CNB listing avocat.fr
Maître Hassan KOHEN, avocat au Barreau de Paris
Hassan KOHEN
Attorney at the Paris Bar

FDA Recalls 4.3 Million Toothpaste Tubes: What French Law Gives You If You Bought a Defective Product

Speak to a lawyer 06 89 11 34 45

On 19 October 2026, the United States Food and Drug Administration classified as Class II the voluntary recall of more than four million tubes of toothpaste manufactured in India by Pritam International Private Limited, including children’s lines sold under the Brush Buddies, Barbie, Hot Wheels and Crayola names. The stated reason in the American enforcement report is short: “CGMP Deviations”. The distribution pattern listed is “US Nationwide”. No recall has been announced in France or in the European Union on the basis of the sources consulted for this article, and no injury has been reported in those same sources. Yet the story matters in Paris for a simple reason: the same tubes travel. They travel in suitcases, through online marketplaces, through friends and family who ship American products to France, and through parallel import circuits that no border check systematically filters for consumer goods. A French consumer holding one of these tubes this week faces a practical question that American coverage does not answer: what does French law do with a defective product that was recalled on the other side of the Atlantic but never recalled here?

This article answers that question in two steps. First, it sets out exactly what the American recall decided, product by product and lot by lot, so that a reader in France can check their own bathroom cabinet. Second, it explains the French remedies: how safety alerts work in France through RappelConso and the European Safety Gate, and how compensation works through the producer’s strict liability for defective products, the seller’s conformity guarantee, and the fault-based action that the Cour de cassation keeps open alongside them. Every rule stated here is taken from a text or a decision read during this run, with its official reference. The analysis is general: it describes the checks and remedies available in any comparable situation and does not describe the situation of any particular company beyond the public facts of the American recall.

I. What the American recall decided: 4.3 million tubes, Class II, manufacturing deviations

A. Which toothpastes were recalled by the FDA and why

The starting point is the official American document, the FDA enforcement report for Event 99849, which records a recall that is “Voluntary: Firm initiated”, initiated on 9 October 2026 by the recalling firm PRITAM INTERNATIONAL PRIVATE LIMITED, Khasra No. 138, Raipur Industrial Area Bhagwanpur, Haridwar, India (FDA enforcement report, Event 99849). The classification date is 19 October 2026, the status is “Ongoing”, and the distribution pattern is “US Nationwide”. The report states that no press release was issued for this recall, which explains why many American consumers learned about it through the press rather than through the manufacturer. According to the American press coverage of 21 and 22 October 2026, more than four million tubes are concerned nationwide, including children’s toothpastes. The same coverage notes that the agency did not publish any detailed explanation beyond the report itself: the FDA did not give a reason for the recall beyond what the enforcement report contains, and it did not immediately respond to requests for more information.

The enforcement report lists the products one by one, with recall numbers, lot codes and quantities. The children’s lines distributed by Ashtel Studios Inc. of Ontario, California, include Brush Buddies Barbie Anticavity Fluoride Toothpaste in bubble gum flavour, Brush Buddies Hot Wheels in strawberry flavour, and several Brush Buddies Crayola Silly Scents references in bubble gum, watermelon and strawberry flavours. Two individual references alone account for more than 800,000 tubes: 409,800 tubes for the Barbie bubble gum reference and 411,600 tubes for the Hot Wheels strawberry reference, identified by their lot numbers and expiry dates running into 2027 and 2028. Alongside the children’s lines, the report covers two Evo products marketed for teeth whitening and sensitivity and two Aru products marketed for gum health and cavity protection. Every line carries the same reason for recall, in the report’s own words: “CGMP Deviations”. Those four letters stand for Current Good Manufacturing Practice deviations, meaning that, according to the American file, the manufacturing process departed from the quality standards the FDA imposes on the production site. The report does not say that the toothpaste contains a named contaminant, and it does not attribute any illness or injury to any tube. That silence matters legally, as this article will show: French product liability does not require proof of a named poison, but it does require proof of a defect, a damage and a causal link.

The classification chosen by the FDA also deserves a precise reading, because American journalists sometimes present it as reassurance and sometimes as alarm, while it is neither: it is a regulatory category. The FDA’s website, as quoted in the American press, defines a Class II recall as the FDA reserves Class II for situations where use of, or exposure to, the product may cause temporary or medically reversible harm while the probability of serious harm is regarded as remote (FDA enforcement scale, as reported by USA Today on 21 October 2026). In plain terms, the American authority considers that serious harm is unlikely but does not exclude temporary or reversible effects. For a French reader, the consequence is practical rather than medical: a Class II product is a product whose safety, in the eyes of the authority that examined its manufacturing file, can no longer be taken for granted. That is exactly the trigger of the French reasoning developed below, where the question is not whether the American classification binds a French court — it does not — but whether a tube presenting the same manufacturing deviation offers, in France, the safety one can legitimately expect from it.

One comparative point gives the French lawyer’s view its edge here, and it concerns the legal nature of toothpaste itself. In the United States, fluoride toothpaste is regulated as a drug: the recalled tubes carry NDC numbers, the National Drug Codes visible in the enforcement report, and the recall runs through the FDA’s drug enforcement process. In France, the same object falls on the other side of the line. Article L5131-1 of the Public Health Code provides: “On entend par produit cosmétique toute substance ou mélange destiné à être mis en contact avec les parties superficielles du corps humain (l’épiderme, les systèmes pileux et capillaire, les ongles, les lèvres et les organes génitaux externes) ou avec les dents et les muqueuses buccales, en vue, exclusivement ou principalement, de les nettoyer, de les parfumer, d’en modifier l’aspect, de les protéger, de les maintenir en bon état ou de corriger les odeurs corporelles.” Toothpaste intended to clean and protect teeth is therefore a cosmetic product under French law, subject to the European cosmetics framework and to the supervision of the health and consumer authorities rather than to the medicines regime. The practical upshot is that a French consumer cannot simply transpose the American drug-recall reflexes: the alert channels, the competent authorities and the compensation routes are the cosmetic and general consumer-product ones, described in the second part of this article.

B. Why a purely American recall still concerns consumers in France

The enforcement report says “US Nationwide”, and no French or European recall of these references appears in the sources consulted for this article. Three channels nevertheless bring American-recalled consumer goods into French homes every year, and toothpaste uses all three. The first is travel: families returning from the United States buy children’s toothpaste in American supermarkets, sometimes in large quantities because the characters on the packaging — Barbie, Hot Wheels, Crayola — are exactly what their children ask for. The second is distance selling: American sellers on international marketplaces ship cosmetics to France, and parcels from relatives complete the flow. The third is parallel import: wholesalers acquire lots intended for the American market and resell them in Europe outside the manufacturer’s official distribution network. None of these channels triggers an automatic French border alert for a product that is perfectly legal in itself. Toothpaste is not a medicine, not a weapon and not a counterfeit: a tube of Brush Buddies in a suitcase looks like any other tube, and customs officers are not equipped with the FDA’s lot lists.

That is why the first useful step for a reader in France is a physical check, not a legal one. Take the tubes bought in the United States or received from across the Atlantic, read the distributor’s name on the packaging — Ashtel Studios Inc., Ontario, California, for the recalled lines — then compare the product name, flavour and, above all, the lot number with the FDA enforcement report. The lots concerned are identified with precision in the report, for example lots LWP250031810502A or LWP250035710304A with expiry dates in 2027 and 2028 for the Barbie bubble gum reference. If the lot matches, the tube belongs to the recalled population even though it sits in a French bathroom: the manufacturing deviation does not disappear at the border. If the lot does not match, or if the tube was bought from the manufacturer’s European distribution with European labelling, the American recall does not concern it as such, although the general vigilance advice below remains valid. Keep the tube, the receipt, the order confirmation and, for online purchases, screenshots of the product page: in every compensation route examined below, the claimant proves what they bought, when, from whom, and which lot they used. A discarded tube is a weakened file.

Two reservations must be stated clearly, because they frame everything that follows. First, at the date of writing and on the basis of the official and press sources read for this article, no illness, no injury and no confirmed case of harm has been attributed to these tubes by any authority. The recall rests on manufacturing deviations, not on a documented poisoning. French law, as shown below, does not require a victim to prove that a product poisoned someone before treating it as defective, but compensation still requires a proven personal damage: worry alone, without a demonstrated harm, does not create a recoverable loss. Second, the FDA’s classification and findings do not bind any French court or authority. They are a serious factual signal — a foreign health authority’s documented finding about identified lots — but a French judge applies French and European texts to the tube actually used in France. The remainder of this article is therefore written in the conditional where the American file is silent, and in the indicative only where a French text or decision speaks.

II. What French law offers a consumer holding a defective product bought in France

A. Safety first: alerts, withdrawals and the RappelConso reflex

French product-safety law starts from a simple architecture: the authorities can have a dangerous product withdrawn or recalled, and consumers can report it so that others are protected. The general regulatory power is stated at Article L412-1 of the Consumer Code, which provides that decrees in the Conseil d’Etat define the rules goods must satisfy and determine, among other things, the conditions under which “l’exportation, l’offre, la vente, la distribution à titre gratuit, la détention, l’étiquetage, le conditionnement ou le mode d’utilisation des marchandises sont interdits ou réglementés”. In practice, for non-food consumer products, the operational tools are the European Safety Gate rapid-alert system, through which Member States notify dangerous products, and the French public portal RappelConso, which lists recalls of products presenting a risk to health or safety and is presented by the public service as the site that identifies recalls of dangerous or defective products. The two systems complement the American one without copying it: a product recalled by the FDA is not automatically listed on RappelConso, and symmetrically a product listed on RappelConso may never have been sold in the United States. Each authority works from its own market surveillance, its own laboratory results and its own legal criteria.

For the holder of a possibly concerned tube, the safety route has four concrete steps. First, stop using the product as soon as the lot match is confirmed or seriously suspected, especially for children: continued use after knowledge of the alert weakens any later claim and, more importantly, exposes the child to the very risk the recall aims to prevent. Second, check RappelConso and the Safety Gate for the product name: if a French or European alert appears, follow its instructions, which specify the remedy offered, typically refund or exchange, and the contact point. Third, if no French alert exists but the tube matches the American recall, report it. Consumers in France can signal a dangerous product through the public reporting channels, and the report should attach the photographs of the packaging, the lot number, the place and date of purchase, and the reference to the FDA enforcement report Event 99849 so that the French authorities can identify the product without ambiguity. A report does not open a right to compensation by itself, but it feeds market surveillance and can trigger the laboratory controls that lead, where justified, to a French measure. Fourth, warn the seller: the retailer or the marketplace seller who sold the tube in France is the first link in the French chain, and a written notice, sent with acknowledgment of receipt and kept with the file, starts the conformity discussion developed below while proving that the seller was informed.

Parents sometimes ask whether they should have their child examined by a doctor even without symptoms. This article gives no medical advice, and no medical examination is a legal condition for any of the remedies below. The legal point is narrower and worth stating precisely: if symptoms appear — irritation, digestive trouble, allergic reaction or anything unusual after use — consult a doctor promptly, describe the product and the lot used, and keep every medical document. Under the liability regime examined next, the claimant must prove the damage, and contemporaneous medical records are the natural proof of bodily harm. Conversely, a medical certificate obtained months later, without any link to the product noted at the time, carries little weight. Evidence is built on the day, not reconstructed afterwards.

B. Being compensated: producer liability, seller conformity, and the deadlines that end claims

French law offers the victim of a defective product two main roads that can be travelled together or separately: an action against the producer for the defective product itself, and an action against the seller for lack of conformity. The two obey different logics, different defendants and different time limits, and confusing them is the most common way of losing a winnable case.

The producer’s liability is a strict liability regime, meaning the victim does not have to prove any fault or negligence by the manufacturer. Article 1245 of the Civil Code states the principle in one sentence: “Le producteur est responsable du dommage causé par un défaut de son produit, qu’il soit ou non lié par un contrat avec la victime.” The absence of any contract with the manufacturer is therefore no obstacle: the family who received the tube from relatives, or who bought it from a retailer, can act directly against the producer. The scope of the regime is set by Article 1245-1 of the Civil Code: “Les dispositions du présent chapitre s’appliquent à la réparation du dommage qui résulte d’une atteinte à la personne. Elles s’appliquent également à la réparation du dommage supérieur à un montant déterminé par décret, qui résulte d’une atteinte à un bien autre que le produit défectueux lui-même.” Bodily injury is therefore covered in full, while damage to other property is covered above the regulatory threshold. The key notion, defect, is defined by Article 1245-3 of the Civil Code: “Un produit est défectueux au sens du présent chapitre lorsqu’il n’offre pas la sécurité à laquelle on peut légitimement s’attendre.” The same article adds that the assessment must take account of all the circumstances, including the presentation of the product, the use that can reasonably be expected of it, and the time of its putting into circulation. A children’s toothpaste in bubble gum flavour, presented with familiar characters and intended to be put in a child’s mouth twice a day, is judged against the safety a parent can legitimately expect from exactly that product — not against the average safety of industrial chemicals in general. And a useful clarification comes from the Cour de cassation: in a case about wine altered by filtration products, the First Civil Chamber quashed an appeal court that had refused to find defectiveness on the ground that the altered wine was harmless to health, holding that what matters is the alteration caused by the incriminated products. The lesson, stated in the court’s own reasoning, is that the liability regime applies “à la réparation, d’une part, du dommage qui résulte d’une atteinte à la personne, d’autre part, du dommage supérieur à 500 euros, qui résulte d’une atteinte à un bien autre que le produit défectueux lui-même, en provoquant sa destruction ou son altération” (Cass. 1re civ., 9 December 2020, No. 19-17.724). Transposed to our facts, the argument would be that toothpaste manufactured in deviation from good manufacturing practice does not offer the safety legitimately expected of children’s toothpaste, whether or not a specific contaminant has been named — but the claimant would still have to prove a personal damage and the causal link, because Article 1245-8 of the Civil Code provides: “Le demandeur doit prouver le dommage, le défaut et le lien de causalité entre le défaut et le dommage.” Three proofs, cumulatively: damage, defect, causation. The American recall helps with the second, since an official foreign finding of manufacturing deviations on identified lots is a serious indication that those lots did not offer expected safety; it proves nothing, by itself, about the first and the third, which depend on the claimant’s own medical and factual file.

The strict-liability road has a companion that victims and even some practitioners overlook: the ordinary fault-based action against the producer, which survives alongside the defective-products regime. The Cour de cassation settled the point in the Mediator litigation, and the reasoning deserves quotation because it governs any case where a producer is said to have known of the risk and kept selling. The court first recalled that the defective-products provisions do not affect the rights the victim can assert under contractual or extra-contractual liability, with the producer remaining liable for the consequences of its own fault. It then drew the operational conclusion: “Il en résulte que la victime d’un dommage imputé à un produit défectueux peut agir en responsabilité contre le producteur sur le fondement du second de ces textes, si elle établit que son dommage résulte d’une faute commise par le producteur, telle qu’un maintien en circulation du produit dont il connaît le défaut ou encore un manquement à son devoir de vigilance quant aux risques présentés par le produit.” (Cass. 1re civ., 15 November 2023, No. 22-21.178). In other words, where the file shows that the producer knew of the defect and kept the product on the market, or breached its vigilance duty regarding the risks, the victim may sue in fault and is not locked into the defective-products regime alone. The textual anchor of that freedom is Article 1245-17 of the Civil Code: “Les dispositions du présent chapitre ne portent pas atteinte aux droits dont la victime d’un dommage peut se prévaloir au titre du droit de la responsabilité contractuelle ou extracontractuelle ou au titre d’un régime spécial de responsabilité. Le producteur reste responsable des conséquences de sa faute et de celle des personnes dont il répond.” Applied prudently to the toothpaste facts, the fault road would require proving that someone in the production or distribution chain knew of the manufacturing deviations and nevertheless kept the concerned lots in circulation — a showing that press articles alone cannot make and that would depend on the documents obtained during the proceedings. It is a second arrow, not a shortcut: it adds a cause of action where knowledge and inertia can be demonstrated, at the cost of proving fault where strict liability asks only for defect, damage and causation.

Both roads against the producer are framed by two time limits that the decisions consulted in this run apply strictly, and that every holder of a concerned tube should have in mind from day one. The first is the prescription of the action itself: Article 1245-16 of the Civil Code provides: “L’action en réparation fondée sur les dispositions du présent chapitre se prescrit dans un délai de trois ans à compter de la date à laquelle le demandeur a eu ou aurait dû avoir connaissance du dommage, du défaut et de l’identité du producteur.” Three years from the day the victim knew or should have known of the damage, the defect and the producer’s identity — three cumulative pieces of knowledge, so that discovering a symptom without knowing which product caused it, or knowing the product without knowing who made it, does not start the clock under the letter of the text. The Mediator decision illustrates the severity of the rule: there, the action served in July 2020 was held prescribed because knowledge of the damage dated back to an expert opinion of October 2015, more than three years earlier. The second limit is the extinction of the regime ten years after the product was put into circulation: Article 1245-15 of the Civil Code provides: “Sauf faute du producteur, la responsabilité de celui-ci, fondée sur les dispositions du présent chapitre, est éteinte dix ans après la mise en circulation du produit même qui a causé le dommage à moins que, durant cette période, la victime n’ait engagé une action en justice.” Ten years from the putting into circulation of the very product that caused the damage, unless court action was started in the meantime — with the stated reservation of the producer’s fault, which refers back to the fault-based road above. The decisions read for this article do not settle every question one might ask about these starting points in the specific case of a foreign recall discovered late, and where the sources are silent this article states no rule: the safe conduct is to act early, to date every discovery in writing, and to have the applicable deadline computed on the complete file rather than guessed from a press article.

The second main road runs against the seller, and it is often the most accessible one for a consumer in France, because the seller is identifiable, reachable and subject to a guarantee that requires no proof of a manufacturing defect. Article L217-3 of the Consumer Code provides: “Le vendeur délivre un bien conforme au contrat ainsi qu’aux critères énoncés à l’article L. 217-5 . Il répond des défauts de conformité existant au moment de la délivrance du bien au sens de l’article L. 216-1 , qui apparaissent dans un délai de deux ans à compter de celle-ci.” Two years from delivery to reveal the lack of conformity, with the seller answering for defects existing at delivery. The content of conformity is broad: Article L217-5 of the Consumer Code provides that, beyond conformity to the contract, goods are conforming where they meet objective criteria, beginning with fitness for normal use: “Il est propre à l’usage habituellement attendu d’un bien de même type, compte tenu, s’il y a lieu, de toute disposition du droit de l’Union européenne et du droit national ainsi que de toutes les normes techniques ou, en l’absence de telles normes techniques, des codes de conduite spécifiques applicables au secteur concerné”. A toothpaste covered by a health authority’s recall for manufacturing deviations, and withdrawn from sale by its own manufacturer, is a textbook candidate for a good that is not fit for its normally expected use — brushing children’s teeth in safety. Against the French seller, the consumer can therefore seek the remedies of the conformity guarantee, which in practice means repair or replacement where possible and, for a low-value consumable that cannot be repaired, refund or price reduction. The seller who objects that the defect comes from the Indian factory misunderstands its own position: the conformity guarantee binds the seller regardless of where the product was made, and it is for the seller to turn against its own supplier afterwards. For purchases from online marketplaces, the analysis is more fact-dependent — platform, third-party seller, place of establishment — but the starting point does not change: identify the contractual seller on the order confirmation and direct the written claim at that party within the two-year window.

In Paris and Île-de-France, these national rules take on local colours worth knowing. The judicial court of Paris hears the consumer and product-liability disputes of the capital’s residents, and its proximity to the national consumer and health authorities makes it the natural forum for files mixing a foreign recall with French purchases. The Paris consumer who bought the tube in a local shop can combine the approaches: immediate written notice to the shop with the lot photographs, report to the surveillance authorities, medical documentation if symptoms exist, and a conflictual claim directed first at the seller under the conformity guarantee, then, where a real damage is proven, at the producer under the defective-products regime, with the fault-based action in reserve where the file shows knowledge and inertia. Keep everything: the tube itself in a sealed bag, the receipt or order confirmation, the screenshots of the product page, the exchange of letters with the seller, the medical certificates. French courts decide product cases on files, and the files that win are the ones built from the first day.

Conclusion

The FDA’s recall of more than four million tubes of toothpaste is an American measure, taken under American drug law, for manufacturing deviations documented on identified lots, with no injury reported in the sources read for this article and no European measure announced on the same basis. None of that leaves a French consumer without protection if the same tube is in their home. French law treats toothpaste as a cosmetic product, organises safety through European alerts and the RappelConso system, holds the producer strictly liable for damage caused by a defect of its product whether or not any contract links them, keeps the fault-based action open where the producer knew of the defect and kept the product in circulation, and guarantees the buyer against the seller that the goods are fit for their normally expected use for two years from delivery. The three proofs — damage, defect, causal link — and the two clocks — three years from triple knowledge, ten years from putting into circulation — decide which of these roads stays open in each individual case. Check the lot number today, keep the tube and the receipt, report the product, write to the seller, and have the deadlines computed on the complete file: in product-safety matters, the law rewards the vigilant and punishes the late.

📄 Official circular